BackUltragenyx Pharmaceutical Overview

Ultragenyx Pharmaceutical Current Assets

Ultragenyx Pharmaceutical's current assets is $540M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$544.00M
↓ 15.42% YoYΔ $-99.21M vs prior year quarter

Peer trimmed avg / median

Loading

Ultragenyx Pharmaceutical Current Assets History

Loading

Ultragenyx Pharmaceutical vs. peers: Current Assets Comparison

Loading

Ultragenyx Pharmaceutical Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ultragenyx Pharmaceutical (RARE) FAQ

As of the most recent data (September 2026), RARE shows a current assets of $540M. That compares with $640M in the prior-year period — down 15.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RARE's current assets is now $540M (was $640M) — a 15.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ultragenyx Pharmaceutical is outperforming or lagging.

Tracking RARE's current assets over time shows whether Ultragenyx Pharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $540M That compares with $640M in the prior-year period — down 15.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Ultragenyx Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $540M) with ownership activity and broader fundamentals.

Ultragenyx Pharmaceutical's current assets is $540M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.